The administration increased the allowable tolerance level for the active compound in kratom products by 20 times the previous recommendation.

Nov 8, 2026

Previously: The administration increased the allowable tolerance level for the active compound in kratom products by 20 times the previous recommendation. [Distorted]: The threshold was loosened, but not 20 times. The July 2026 proposal drew the line at 0.05% 7-OH, which is 0.5 milligrams per gram. The October 2026 update from HHS and the Justice Department moved it to 1 milligram per gram or per milliliter, which doubles the concentration limit. The update also dropped the earlier 1 milligram per article cap, so a large bottle could now legally hold more in total, but the concentration Means was describing rose about 2 times, not 20. A federal document showing the allowed 7-OH concentration rose twentyfold would prove this verdict wrong.

Now: The administration increased the allowable tolerance level for the active compound in kratom products by 20 times the previous recommendation. [Distorted]: The published proposals do not show a 20-fold change in the stated concentration threshold. July specified 0.050%, equivalent to 0.5 mg/g; October specified 1 mg/g for solids or 1 mg/mL for liquids, plus a separate mitragynine-ratio condition. That concentration comparison is twofold. The earlier per-article trigger and changed definitions prevent treating this as a simple equivalent dosing allowance. These were scheduling proposals, not FDA findings of a safe consumption dose. No final 7-OH order could issue before November 13 under the October notice.

Deeper review against transcript context and primary evidence.